Posttraumatic stress symptoms in carers of people with psychosis Sample Clauses

Posttraumatic stress symptoms in carers of people with psychosis. Research indicates that the conditions surrounding the onset of psychosis can also often be medically aversive and distressing for both patients and carers (Xxxxxx et al., 1998; Xxxxxx et al., 2003). Carers can interpret the risk of patient suicide and illness related stigma (Xxxxxxxxx et al., 2001) as potentially threatening and some carers may become the focus of paranoid ideas or delusions, which result in their relative threatening, or causing them, actual bodily harm (Xxxxxxxx & Hubband, 2003). As part of their role, carers of people with psychosis report exposure to a broad range of aggressive behaviours, including verbal, physical, self-directed and sexual aggression (Xxxxxxxx & Hubband, 2003; Xxxxxxxxx et al., 2009; Xxxxxxx, Xxxxxx, Xxxxxxxx, & Adlard, 1997). Substance use among individuals with schizophrenia is frequent (Xxxxx, Xxxxx, Xxxxxxxx, & Xxxxxxx, 2007) and often associated with verbal or physical aggression towards caregivers (Xxxxxxx et al., 1997). In a qualitative study of couples caring for adult children with psychosis, results indicated that some carers described feeling “frightened for our lives” (Xxxx, Xxxxxx, Xxxx-Gray, & Xxxxx, 2009). The authors commented that many of the accounts were reminiscent of trauma narratives and emotions of fear, frustration and helplessness were still evident despite many years of service involvement and caring. Furthermore, there is now substantial evidence of posttraumatic stress symptoms in individuals with psychosis (e.g., Shaw et al., 2002; Xxxxx & Xxxxxxxx, 2001) therefore carers may be at risk of secondary or vicarious traumatization as seen, for example, in partners of veterans (Xxxxxxxx & Xxxxx, 2004). As indicated by the DSM-IV, significant others can be significantly affected by a traumatic event that they witness or learn of. Xxxx and Xxxx (2002) found that relatives of acutely admitted psychotic patients experienced strong acute and persistent stress responses, similar to those described in those exposed to severe or life threatening illness. More recently, Xxxxxx and Xxxxxxx (2008) found that in a sample of people caring for someone with recent onset psychosis, more than one-third (35.1%) reported symptoms of traumatic stress. Similarly, in a sample of carer-relatives, Xxxxxxxxx et al. (2009) found that over two thirds (77%) reported experiencing moderate-severe aggression and approximately half of these carer-relatives reported significant posttraumatic stress symptoms. In this study, a...
Sample 1
AutoNDA by SimpleDocs
Posttraumatic stress symptoms in carers of people with psychosis. The level of posttraumatic stress symptoms found in this sample are consistent with figures reported in other studies measuring posttraumatic stress symptoms in carers of people with psychosis (Xxxxxx & Xxxxxxx, 2008; Xxxxxxxxx et al., 2009). The types of carer related events reported as traumatic have also been identified in previous studies with carers of people with psychosis, for example aggression (Xxxxxxxx & Hubband, 2003; Loughland et al., 2009) and risk of suicide (Struening et al., 2001). Of interest was the high rate of previous trauma reported by carers that was unrelated to the caring role and this needs to be considered when interpreting the results especially in relation to self-report measures of posttraumatic stress symptoms. Although, it should be noted that these events were identified in response to an open ended question and not assessed to determine if they meet current diagnostic definitions of traumatic events (i.e., Criterion A on the SCID PTSD module). Given the overall lifetime prevalence rates of exposure to traumatic events in the general population (89.6%; Breslau et al., 1998), it is conceivable that a significant proportion of the current sample would also be expected to report a history of these experiences. Only one carer in this study was found to meet criteria for PTSD, based on data drawn from a structured clinical interview. There are no known previous studies using a formal diagnostic interview to assess PTSD in carers of people with psychosis. The 3% prevalence rate for PTSD in response to events related to caring for someone with psychosis is slightly lower than figures published in studies using formal structured clinical interviews with other clinical groups; for example, parents of children with life threatening physical illnesses (7%, Stoppelbein & Xxxxxxxx, 2007; 6.2%, Xxxxx, Xxxxx, Xxxxxxxx, Xxxxxx, & Xxxx, 1998; 13.7%, Xxxxx et al., 2004) and mothers of children undergoing bone marrow transplantation (7.8%; Xxxxx et al., 2002). The current 3% figure is also lower than the risk of PTSD following exposure to trauma in general population studies (9.2%; Breslau et al., 1998). However, the sample size is likely to be too small to reliably estimate prevalence rates in this population; further studies with larger sample sizes would be indicated. Moreover, the percentage rate obtained in the current study only represents the presence of PTSD in relation to traumatic events related to the caring role. In contrast, more...
Sample 1

Related to Posttraumatic stress symptoms in carers of people with psychosis

  • CHILD AND DEPENDENT ADULT/ELDER ABUSE REPORTING CONTRACTOR shall establish a procedure acceptable to ADMINISTRATOR to ensure that all employees, agents, subcontractors, and all other individuals performing services under this Agreement report child abuse or neglect to one of the agencies specified in Penal Code Section 11165.9 and dependent adult or elder abuse as defined in Section 15610.07 of the WIC to one of the agencies specified in WIC Section 15630. CONTRACTOR shall require such employees, agents, subcontractors, and all other individuals performing services under this Agreement to sign a statement acknowledging the child abuse reporting requirements set forth in Sections 11166 and 11166.05 of the Penal Code and the dependent adult and elder abuse reporting requirements, as set forth in Section 15630 of the WIC, and shall comply with the provisions of these code sections, as they now exist or as they may hereafter be amended.

  • Cosmetic Surgery Any non-medically necessary surgery or procedure whose primary purpose is to improve or change the appearance of any portion of the body to improve self-esteem, but which does not restore bodily function, correct a diseased state, physical appearance, or disfigurement caused by an accident, birth defect, or correct or naturally improve a physiological function. Cosmetic Surgery includes, but is not limited to, ear piercing, rhinoplasty, lipectomy, surgery for sagging or extra skin, any augmentation or reduction procedures (e.g., mammoplasty, liposuction, keloids, rhinoplasty and associated surgery) or treatment relating to the consequences or as a result of Cosmetic Surgery.

  • Tuberculosis Examination The examination shall consist of an approved intradermal tuberculosis test, which, if positive, shall be followed by an X-ray of the lungs. Nothing in Sections 5163 to 5163.2, inclusive, shall prevent the governing body of any city or county, upon recommendation of the local health officer, from establishing a rule requiring a more extensive or more frequent examination than required by Section 5163 and this section. § 5163.2. Technician taking X-ray film; Interpretation of X-ray The X-ray film may be taken by a competent and qualified X-ray technician if the X-ray film is subsequently interpreted by a licensed physician and surgeon.

  • Infectious Disease Where an employee produces documentary evidence that:

  • Diagnosis For a condition to be considered a covered illness or disorder, copies of laboratory tests results, X-rays, or any other report or result of clinical examinations on which the diagnosis was based, are required as part of the positive diagnosis by a physician.

  • Pharmacy Benefits - Prescription Drugs and Diabetic Equipment or Supplies from a Pharmacy This plan covers prescription drugs listed on our formulary and diabetic equipment or supplies bought from a pharmacy as a pharmacy benefit. These benefits are administered by our Pharmacy Benefit Manager (PBM). Our formulary includes a tiered copayment structure and indicates that certain prescription drugs require preauthorization. If a prescription drug is not on our formulary, it is not covered. For specific coverage information or a copy of the most current formulary, please visit our website or call our Customer Service Department. Prescription drugs and diabetic equipment or supplies are covered when dispensed using the following guidelines: • the prescription must be medically necessary, consistent with the physician’s diagnosis, ordered by a physician whose license allows him or her to order it, filled at a pharmacy whose license allows such a prescription to be filled, and filled according to state and federal laws; • the prescription must consist of legend drugs that require a physician’s prescription under law, or compound medications made up of at least one legend drug requiring a physician’s prescription under law; • the prescription must be dispensed at the proper place of service as determined by our Pharmacy and Therapeutics Committee. For example, certain prescription drugs may only be covered when obtained from a specialty pharmacy; and • the prescription is limited to the quantities authorized by your physician not to exceed the quantity listed in the Summary of Pharmacy Benefits. Prescription drugs are subject to the benefit limits and the amount you pay shown in the Summary of Pharmacy Benefits.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Organ Transplants This plan covers organ and tissue transplants when ordered by a physician, is medically necessary, and is not an experimental or investigational procedure. Examples of covered transplant services include but are not limited to: heart, heart-lung, lung, liver, small intestine, pancreas, kidney, cornea, small bowel, and bone marrow. Allogenic bone marrow transplant covered healthcare services include medical and surgical services for the matching participant donor and the recipient. However, Human Leukocyte Antigen testing is covered as indicated in the Summary of Medical Benefits. For details see Human Leukocyte Antigen Testing section. This plan covers high dose chemotherapy and radiation services related to autologous bone marrow transplantation to the extent required under R.I. Law § 27-20-60. See Experimental or Investigational Services in Section 3 for additional information. To speak to a representative in our Case Management Department please call 1-401- 000-0000 or 1-888-727-2300 ext. 2273. The national transplant network program is called the Blue Distinction Centers for Transplants. SM For more information about the Blue Distinction Centers for TransplantsSM call our Customer Service Department or visit our website. When the recipient is a covered member under this plan, the following services are also covered: • obtaining donated organs (including removal from a cadaver); • donor medical and surgical expenses related to obtaining the organ that are integral to the harvesting or directly related to the donation and limited to treatment occurring during the same stay as the harvesting and treatment received during standard post- operative care; and • transportation of the organ from donor to the recipient. The amount you pay for transplant services, for the recipient and eligible donor, is based on the type of service.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. How to File an Expedited Appeal Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.

  • Musculoskeletal Injury Prevention and Control (a) The Hospital in consultation with the Joint Health and Safety Committee (JHSC) shall develop, establish and put into effect, musculoskeletal prevention and control measures, procedures, practices and training for the health and safety of employees.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!